BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12039985)

  • 1. Two gene fragments that direct podocyte-specific expression in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    J Am Soc Nephrol; 2002 Jun; 13(6):1561-7. PubMed ID: 12039985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new tool for exploring podocyte biology: mouse Nphs1 5' flanking region drives LacZ expression in podocytes.
    Moeller MJ; Kovari IA; Holzman LB
    J Am Soc Nephrol; 2000 Dec; 11(12):2306-2314. PubMed ID: 11095653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1 activates a glomerular-specific enhancer identified from the human nephrin gene.
    Guo G; Morrison DJ; Licht JD; Quaggin SE
    J Am Soc Nephrol; 2004 Nov; 15(11):2851-6. PubMed ID: 15504938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a viral T2A-peptide based knock-in mouse model for enhanced Cre recombinase activity and fluorescent labeling of podocytes.
    Koehler S; Brähler S; Braun F; Hagmann H; Rinschen MM; Späth MR; Höhne M; Wunderlich FT; Schermer B; Benzing T; Brinkkoetter PT
    Kidney Int; 2017 Jun; 91(6):1510-1517. PubMed ID: 28187984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lmx1b and FoxC combinatorially regulate podocin expression in podocytes.
    He B; Ebarasi L; Zhao Z; Guo J; Ojala JR; Hultenby K; De Val S; Betsholtz C; Tryggvason K
    J Am Soc Nephrol; 2014 Dec; 25(12):2764-77. PubMed ID: 24854274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible podocyte-specific gene expression in transgenic mice.
    Shigehara T; Zaragoza C; Kitiyakara C; Takahashi H; Lu H; Moeller M; Holzman LB; Kopp JB
    J Am Soc Nephrol; 2003 Aug; 14(8):1998-2003. PubMed ID: 12874453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
    Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
    Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular-specific gene excision in vivo.
    Eremina V; Wong MA; Cui S; Schwartz L; Quaggin SE
    J Am Soc Nephrol; 2002 Mar; 13(3):788-793. PubMed ID: 11856786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the type I insulin-like growth factor receptor (IGF-IR) in glomerular integrity.
    Bridgewater DJ; Dionne JM; Butt MJ; Pin CL; Matsell DG
    Growth Horm IGF Res; 2008 Feb; 18(1):26-37. PubMed ID: 17689124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
    Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice.
    Rossert J; Eberspaecher H; de Crombrugghe B
    J Cell Biol; 1995 Jun; 129(5):1421-32. PubMed ID: 7775585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chick delta1-crystallin enhancer influences mouse alphaA-crystallin promoter activity in transgenic mice.
    Reneker LW; Chen Q; Bloch A; Xie L; Schuster G; Overbeek PA
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4083-90. PubMed ID: 15505059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a glomerular-specific promoter from the human nephrin gene.
    Wong MA; Cui S; Quaggin SE
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1027-32. PubMed ID: 11097620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glowing podocytes in living mouse: transgenic mouse carrying a podocyte-specific promoter.
    Imai E; Akagi Y; Isaka Y; Ikawa M; Takenaka M; Hori M; Okabe M
    Exp Nephrol; 1999; 7(1):63-6. PubMed ID: 9892816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte injury and albuminuria in mice with podocyte-specific overexpression of the Ste20-like kinase, SLK.
    Cybulsky AV; Takano T; Papillon J; Guillemette J; Herzenberg AM; Kennedy CR
    Am J Pathol; 2010 Nov; 177(5):2290-9. PubMed ID: 20889563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
    Petrakis I; Mavroeidi V; Stylianou K; Andronikidi E; Lioudaki E; Perakis K; Stratigis S; Vardaki E; Zafeiri M; Giannakakis K; Plaitakis A; Amoiridis G; Saraiva MJ; Daphnis E
    Amyloid; 2013 Sep; 20(3):164-72. PubMed ID: 23829269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the mouse CSF-1 gene promoter in a transgenic mouse model.
    Abboud SL; Bunegin M; Ghosh-Choudhury N; Woodruff K
    J Histochem Cytochem; 2003 Jul; 51(7):941-9. PubMed ID: 12810844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of Nephrin Reporter Mice and Use for Chemical Screening.
    Tsuchida J; Matsusaka T; Ohtsuka M; Miura H; Okuno Y; Asanuma K; Nakagawa T; Yanagita M; Mori K
    PLoS One; 2016; 11(6):e0157497. PubMed ID: 27362433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.